Kindred Biosciences, Inc. logo

Kindred Biosciences, Inc. KIN

$ 9.25 0.11%

Country

usaUSA

IPO year

2013

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Richard Chin

Employees in the company

156

Shares

39.3 M

Market Cap[1]

$ 419 M

EBITDA (LTM)

$ 834 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.